Metformin and Linagliptin

Therapeutic indications

Metformin and Linagliptin is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Linagliptin/metformin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:

  • in patients inadequately controlled on their maximally tolerated dose of metformin alone
  • in combination with other medicinal products for the treatment of diabetes, including insulin, in patients inadequately controlled with metformin and these medicinal products
  • in patients already being treated with the combination of linagliptin and metformin as separate tablets.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Metformin and Linagliptin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: JENTADUETO Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈